Embed Size (px)
Citation preview
www.euronanomed.net
EUROpean network of transnational collaborative RTD projects
in the field of NANOMEDicine
www.euronanomed.net
What are the societal needs? - the challenge for Europe
Improve public health and welfare– Ageing population– Efficiency of current medical
solutions– Emergence of new disease and old
diseases are back– Personalized medicine future
directions
www.euronanomed.net
The global challenge
• Therapeutic solutions for only 1/3 known diseases (WHO)
• Infections: HIV, TB, malaria, risk of pandemia
• Need to increase capability and innovation of medical industry– Rapid and accurate diagnosis for
early detection, even prevention– Novel, more efficient therapies with
less side effects
www.euronanomed.net
Nano from research to patient and industry
Nanomedicine: the application of nanotechnology to achieve breakthroughs in healthcare
Foto: kaibara87/www.flickr.com
www.euronanomed.net
Emerging nanomedicine
Lancet Infectious Diseases
April issue, vol 9, 2009
www.euronanomed.net
Principle of theERA-net scheme
F
G
UK
ES
DE
CP
CP
CP
CP
CP
Without ERA-Net
Prog
FProg
GProg
UKProg
ESProg
DE
Common transnational dedicated CP
With ERA-Net
…
(CP: Call for projects)
€ : EC supports the coordination costs. Each national programme supports their national partners within the selected projects
www.euronanomed.net
EuroNanoMed covers 3/4 of European
nanomedicine actors
• 24 partners from 18 countries/regions
• Coordination of funding programmes in nanomedicine
• Started January 2009
• EU funding for coordination for coordination ((ERA-net in FP7)
2 common joint calls for proposals 2009, 2010
www.euronanomed.net
EuroNanoMed: an asset to bridge the gap
2 calls to support RTD projects aiming at– solving an unmet medical need using
nanomedicine– promoting a multidisciplinary translational
approach with an international focus
EuroNanoMed will achieve
a critical mass of actors !!!
www.euronanomed.net
EuroNanoMed outputs
• Develop innovative diagnostic and therapeutic solutions for the patient, enhancing the competitiveness of the European health industry
• Maturation of the field To bring together – academic teams – clinical/public health teams– industrial research teams
• Cross-border collaboration between the best researchers/teams in nanomedicine
www.euronanomed.net
Why now? What’s the urgency?
• Health industry: a key for future growth
• European countries invest substantially in nano industry and basic nano research
• Nano technologies: a promising field for innovation and patient application
Despite these efforts, Europe is lagging behind the US in an increasing competition :
Europe needs to act now!
www.euronanomed.net
Expected outcome
• To move innovation from knowledge to industrial technology and health care applications
• Opening the national programmes to support transnational RTD partnerships
Long term vision: formula for an European-
wide integrated programme with a coordinated funding
www.euronanomed.net
Contacts
• CoordinatorDr. Pierre-Noël LIRSAC Commissariat à l’Energie Atomique (CEA)[email protected], [email protected] (+33) 1 69 08 87 99
• Network Steering Committee chair Associate Prof. Karin Forsberg-NilssonSwedish research Council (SRC)
www.euronanomed.net
EuroNanoMed ERA
Networking towards ERA!
www.euronanomed.net
EuroNanoMed First joint transnational call
for proposals
18 partners
16 countries/regions
www.euronanomed.net
Funding organisations in the first call for proposals• Industry, Trade and Tourism Department, Basque Government (ITT), Basque region (Spain)• Swiss National Science Foundation (SNSF), Switzerland• VDI Technologiezentrum GmbH, Germany• Instituto de Salud Carlos III (ISCIII), Spain • The French National Research Agency (ANR), France• The Chief Scientist Office, The Ministry of Health (CSO-MOH), Israel• The Icelandic Centre for Research (RANNIS), Iceland• The Latvian Academy of Sciences (LAS), Latvia• SenterNovem, The Netherlands• National Centre for Research and Development (NCBiR), Poland• Fundacao para a Ciencia e a Tecnologia (FCT), Portugal• National Center for Programme Management (CNMP), Romania• The Swedish Research Council (SRC)(Vetenskapsrådet), Sweden• The Swedish Governmental Agency for Innovation Systems (VINNOVA ), Sweden• The Scientific and Technological Research Council of Turkey (TUBITAK), Turkey• Science Council of Lithuania (LSC), Lithuania• Economic development, research and innovation Directorate, Veneto region (Italy)• Public Service of Wallonia: Operational General Directorate for Economy, Employment,
and Research (DGOEER), Walloon Region (Belgium)
www.euronanomed.net
Topics
• Diagnostics
• Targeted drug delivery
• Regenerative medicine
www.euronanomed.net
Aim of the 1st call for proposals
• To find new medical solutions
• To enable an effective multi-national collaboration on research projects– Promoting multidisciplinary efforts– Encouraging translational research proposals that
combine either basic/clinical and/or industrial approach
– Having an added value in funding the transnational collaboration over the individual projects
• To support novel, ambitious ideas and possibility of application to end users
www.euronanomed.net
Eligibility criteria
Consortia with room for flexibility– 3 -7 partners from at least three partnering countries
– At least one clinical/public health research team and/or one industrial research team per consortium
– At least two categories (academic/clinical/industrial teams)
– Project consortium partners´ eligibility depends upon national regulation
www.euronanomed.net
Funding, 1st call
• Indicative total funding 15-20 M€
• Funding for up to 3 years
• Selected projects receive funding directly from their corresponding national/regional funding bodies after meeting their national regulations
www.euronanomed.net
Time lines, 1st call
• Call opens: End of May 2009
• Call closes: September 1st 2009
• Funding decision: December 2009
www.euronanomed.net
For more information
• EuroNanoMed Call officeVeneto Nanotech s.c.p.a.
Via San Crispino, 10635129 Padova – Italy
: +39 049 7705520
email: [email protected]: www.euronanomed.net
• National/regional contacts
www.euronanomed.net
Together we're building nanomedicine for the future!
